Needle core biopsy and open biopsy of breast lesions: Comparison of histologic results and expression of hormone receptors and Ki-67

被引:5
作者
Mayer, R
Mielke, G
Oettling, G
Geppert, M
Stoll, P
Wallwiener, D
机构
[1] Univ Tubingen, Frauenklin, D-72076 Tubingen, Germany
[2] Inst Zytol Diagnost Nurnberg, Nurnberg, Germany
关键词
D O I
10.1055/s-1999-5983
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose: To compare histologic findings and immunohistochemical staining for steroid hormone receptors and the nuclear proliferation Ki-67 in needle core biopsies and specimens subsequently obtained at open breast biopsy. Material and Methods: 58 patients underwent ultrasound-guided percutaneous needle biopsy of breast lesions. 48 lesions were subsequently excised. Expression of hormone receptors was evaluated immunohistochemically by the number and staining intensity of cells (n = 35). Ki-67 expression was assessed semiquantitatively on the basis of the number of positive cells (n = 14). Results: 48 core biopsie specimens were diagnosed as carcinoma and 8 as benign lesions. One biopsy contained no tissue and another showed epithelial cells without nuclei; at open biopsy both these lesions were carcinomas. No complications occurred. Hormone receptor status was compared in 35 cases. All but estrogen-receptor-positive surgical specimens were associated with positive biopsy specimens, except one technically inadequate biopsy (97%). Progesterone receptor status agreed in 31 cases (89%). Two biopsy specimens were technically inadequate. Two biopsies were negative while the surgical specimens were positive. One tumor showed homogenous but weak expression whereas the other showed heterogenous expression. Ki-67 activity was analyzed in 14 cases and agreed in 13 (98%). Conclusions: Ultrasound-guided needle core biopsy is an accurate technique for evaluating breast lesions. In breast carcinomas, hormone receptor status and Ki-67 expression can be assessed with a high degree of accuracy.
引用
收藏
页码:566 / 568
页数:3
相关论文
共 20 条
[1]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[2]  
[Anonymous], FRAUENARZT
[3]  
AZEVADO E, 1989, LANCET, V1, P1033
[4]  
Bajetta E, 1998, INT J ONCOL, V12, P853
[5]  
Bernstein JR, 1996, SEMIN SURG ONCOL, V12, P290, DOI 10.1002/(SICI)1098-2388(199609/10)12:5<290::AID-SSU3>3.3.CO
[6]  
2-2
[7]  
Biesterfeld S, 1997, ANTICANCER RES, V17, P4723
[8]  
Burns RP, 1997, AM J SURG, V173, P9, DOI 10.1016/S0002-9610(96)00374-1
[9]  
Gillett CE, 1997, BRIT J BIOMED SCI, V54, P47
[10]   Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer [J].
Honkoop, AH ;
van Diest, PJ ;
de Jong, JS ;
Linn, SC ;
Giaccone, G ;
Hoekman, K ;
Wagstaff, J ;
Pinedo, HM .
BRITISH JOURNAL OF CANCER, 1998, 77 (04) :621-626